ESOP16 Jun 2026, 01:17 pm
Cipla Ltd: Board Approves Stock Options & ESARs Grant
AI Summary
Cipla Ltd announced that its Board of Directors has approved the grant of stock options and Employee Stock Appreciation Rights (ESARs) under its existing schemes. The board also approved the appointment of Mr. Shivam Puri as the Chief Executive Officer – One India Business, effective July 1, 2026. Mr. Puri, currently CEO of Cipla Health Limited, brings over 23 years of experience in FMCG and healthcare. The grants include 11,360 stock options under ESOS 2013-A and 51,394 ESARs under ESAR 2021, with specified vesting and exercise periods. The exercise price for both is ₹2 per option/share.
Key Highlights
- Board approved grant of stock options and ESARs.
- Shivam Puri appointed CEO – One India Business from July 1, 2026.
- 11,360 stock options granted under ESOS 2013-A.
- 51,394 ESARs granted under ESAR 2021.
- Exercise price set at ₹2 for both options and ESARs.
Price Impact
More from CIPLA